Bronwyn Stuckey

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 2.8K citations · Full text

Metabolic Syndrome, Diabetes Management, Cardiovascular Disease +9

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 600 citations · Full text

Metabolic Syndrome, Diabetes Management, Urology +10

Assessment and management of polycystic ovary syndrome: summary of an evidence‐based guideline

Helena Teede, Marie Misso, Amanda Deeks et al. · The Medical Journal of Australia · 2011 · 372 citations

Testosterone treatment to prevent or revert type 2 diabetes in men enrolled in a lifestyle programme (T4DM): a randomised, double-blind, placebo-controlled, 2-year, phase 3b trial

Gary Wittert, Karen Bracken, Kristy Robledo et al. · The Lancet Diabetes & Endocrinology · 2020 · 334 citations

Metabolic Syndrome, Diabetes Management, Andrology +7

Combined Thyroxine/Liothyronine Treatment Does Not Improve Well-Being, Quality of Life, or Cognitive Function Compared to Thyroxine Alone: A Randomized Controlled Trial in Patients with Primary Hypothyroidism

John P. Walsh, Lauren Shiels, Ee Mun Lim et al. · The Journal of Clinical Endocrinology & Metabolism · 2003 · 213 citations · Full text